Dofequidar fumarate (MS-209) in combination with cyclophosphamide, doxorubicin, and fluorouracil for patients with advanced or recurrent breast cancer (Q79441667)

From Wikidata
Jump to navigation Jump to search
scientific article published on 18 December 2006
edit
Language Label Description Also known as
English
Dofequidar fumarate (MS-209) in combination with cyclophosphamide, doxorubicin, and fluorouracil for patients with advanced or recurrent breast cancer
scientific article published on 18 December 2006

    Statements

    title
    Dofequidar fumarate (MS-209) in combination with cyclophosphamide, doxorubicin, and fluorouracil for patients with advanced or recurrent breast cancer (English)
    1 reference
    stated in
    Europe PubMed Central
    PubMed publication ID
    17179098
    reference URL
    https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17179098%20AND%20SRC:MED&resulttype=core&format=json
    retrieved
    23 December 2019
    author name string

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q79441667&oldid=1756359055"